SpaceX Starship Test Key Milestone Ahead of Potential IPO Applied Materials Insider Files Form 144 for Potential Share Sale Toyota Pauses NextGen Lexus EV Development Amid Strategy Shift Iran Publishes Map Asserting Control Over Strait of Hormuz Raising Geopolitical Tensions Bitcoin and Ethereum Prices Open at Weekly Lows on May 27 2026 PutinXi Talks Set to Revive Stalled Power of Siberia 2 Pipeline as Iran Conflict Ripples Through Energy Markets Antero Resources Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Declines RCAT Q1 2026 Earnings EPS Misses Estimates by 7147 Amid Continued Investment in Drone Technology ESLA Q1 2026 Earnings WiderThanExpected Loss and No Revenue Highlight DevelopmentStage Challenges MPLT Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution Garrett Motion Q1 2026 Earnings EPS Surges Past Estimates Amidst Limited Revenue Disclosure Blue Acquisition Corp BACC Holds Steady at 1035 as Trading Range Narrows Social Commerce Partners Corporation Unit SCPQU Holds Steady at 1006 as Trading Activity Stabilizes Myomo Inc MYO Surges 95 as Medical Device Penny Stock Breaks Above Key Support Liquidia Corporation LQDA Gains 32 as Biotech Momentum Builds Key Levels Ahead Kelly Services KELYA Surges 374 Testing Resistance After Breaking Above Support UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister CZNC Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher INLIF LIMITED INLF Slides 51 as Key Support Level Looms CTS Q1 2026 Earnings EPS Surges Past Estimates Stock Slips Battalion Oil Corporation BATL Q2 2023 Earnings NarrowerThanExpected Loss Amid Continued Operational Challenges YORW Q1 2026 Earnings EPS Beats Estimates as Regulated Utility Shows Steady Performance RDDT Q1 2026 Earnings EPS Blowout Surprises Wall Street Yet Shares Slide LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations CCLD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Upstream Bio Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress